The World Health Organization has released its first global guideline on treating obesity in children and adolescents, according to DW.com. The guidance, published on Wednesday, October 7, 2026, favors nutrition and physical activity as the primary approach for young people living with obesity, rather than weight-loss injections commonly known as "skinny pens."
DW.com reports that the recommendation marks a shift in emphasis toward lifestyle-based care for this age group. The guideline is the first of its kind from the WHO covering obesity in children and adolescents, a development also reported by Agência Brasil, Estadão, VEJA and O Globo.
Coverage of the guideline notes that it addresses medication as well. According to O GLOBO, the WHO indicates for the first time that drugs may be used in this population, including injectable weight-loss treatments. That positions the guidance as a dual message: lifestyle change first, with pharmaceutical options acknowledged rather than ruled out entirely.
The guideline arrives as obesity among young people remains a global health concern, and as appetite-suppressing medications have drawn growing attention. The WHO's entry into this area gives national health authorities a shared reference point where none previously existed at the global level.
What to watch next: how individual countries translate the WHO's recommendations into their own treatment protocols, and whether the conditions attached to any recommended use of medication for minors become clearer.
